In 2010, Sysmex Corporation aquired HYPHEN BioMed enabling us to provide a comprehensive line of reagents to compliment our existing Siemens haemostasis reagents portfolio.

HYPHEN BioMed is a scientific company with experience in the field of thrombosis, haemostasis and auto-immunity, producing a full line of diagnostic and research reagents, distributed worldwide.